Skip to main content
Language DelayAddictionMental healthBehavioralBehavioral

What this study is

The goal of this clinical trial is to test ways to improve early language development among young children of parents with substance use disorder (SUD). Children of parents with SUD are at increased risk for language delays, and early supports may help prevent long-term learning challenges. This study will examine whether adding additional supports to group-based parenting intervention improves child language outcomes compared to the group intervention alone.

What's being tested

  • Comilia Group

    Intervention · BEHAVIORAL

    Parents participate in six weekly 90-minute in-person groups led by a trained facilitator and offered in English or Spanish. Groups use modeled caregiver-child interaction videos and guided discussion to teach evidence-based communication strategies.

  • Interaction Review Enhancement

    Intervention · BEHAVIORAL

    Parents receive three one-hour telehealth coaching sessions with a licensed speech-language pathologist to review caregiver-child interactions, practice communication strategies, and receive individualized feedback.

  • Practical Support Enhancement

    Intervention · BEHAVIORAL

    Participants receive three one-hour telehealth sessions focused on identifying barriers to using the communication strategies introduced in the group sessions. Interventionists work with parents to develop structured supports (e.g., mindfulness tools, visual aids, tracking logs, timers) and set goals to address planning, attention, or memory challenges that may interfere with implementation.

Study details

Official title
Evidence-based Intervention Enhancements to Reduce Language Delays and Disorders Among Children of Parents With Substance Use Disorders
Sponsor
University of Oregon
Conditions
Language Delay · Substance Use Disorders · Language Disorders in Children · Language Development · Prevention Intervention
Enrolling
244 people
Starts
2026-03-10
Est. completion
2029-11-30
Design
Single-blind, randomized, factorial
Record
View on ClinicalTrials.gov ↗